Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635

Neuropsychopharmacology

Volumn 24, Issue 1, 2001, Pages 11-20

  Hervás, Ildefonso ^a   Vilaró, M Teresa ^a   Romero, Luz ^a   Scorza, M Cecilia ^a   Mengod, Guadalupe ^a   Artigas, Francesc ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

5 HT(1A) receptors; 5 Hydroxytryptamine uptake; Dorsal raphe nucleus; Frontal cortex; Microdialysis; Selective serotonin reuptake inhibitors (SSRI)

Indexed keywords

AUTORECEPTOR; FLUOXETINE; MESSENGER RNA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG RECEPTOR BINDING; FRONTAL CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR DENSITY; RECEPTOR SENSITIVITY; SEROTONIN BRAIN LEVEL;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BRAIN; DEPRESSIVE DISORDER; FLUOXETINE; MALE; NEURONS; PIPERAZINES; PYRIDINES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0035205403     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00175-5     Document Type: Article

References (60)

1. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo microdialysis study
2. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat
3. 5-HT(1A) receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram
4. The 5-HT(1A) receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram
5. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
6. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT(1A) antagonists
7. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo
8. Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration
9. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei
10. Reduction of serotonergic function in rat brain by tryptophan depletion. Effects in control and fluvoxamine-treated rats
11. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: A double-blind, placebo-controlled trial
12. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression
13. Modification of 5-HT neuron properties by sustained administration of the 5-HT(1A) agonist gepirone: Electrophysiological studies in the rat brain
14. Current advances and trends in the treatment of depression
15. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: Intermediate analysis of a double-blind, placebo- controlled trial
16. Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5- HT(1A) and 5-HT(1B) receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats
17. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat
18. Differential regulation of somatodendritic serotonin 5-HT(1A) receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(di-n-propylamino)tetralin: Microdialysis and autoradiographic studies in rat brain
19. Postsynaptic 5-HT(1A) receptors control 5-HT release in the rat medial prefrontal cortex
20. Effects of chronic fluoxetine treatment, in the presence and absence of 5-HT(1A) receptor blockade, on extracellular 5-HT. A microdialysis study
21. Alteration of 5-HT(1A) receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography
22. Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment relationship with brain concentrations of fluoxetine and norfluoxetine
23. Interaction between a selective 5-HT(1A) receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT
24. Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: Role of 5-HT(2C) receptors
25. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: This effect persists after repeated citalopram treatment
26. Effects of the co-administration of 5-HT(1A) receptor antagonists with an SSRI in conditioned fear stress- induced freezing behavior
27. A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments
28. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors
29. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat
30. Lack of 5-HT(1A) autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis
31. Further evidence for the importance of 5-HT(1A) autoreceptors in the action of selective serotonin reuptake inhibitors
32. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: Role of presynaptic 5-HT(1A) receptors
33. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram
34. Chronic alnespirone-induced desensitization of somatodendritic 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus
35. Early desensitization of somato-dendritic 5-HT(1A) autoreceptors in rats treated with fluoxetine or paroxetine
36. Chronic fluoxetine induces a gradual desensitization of 5-HT(1A) receptors: Reductions in hypothalamic and midbrain G(i) and G(o) proteins and in neuroendocrine responses to a 5-HT(1A) agonist
37. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression
38. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance
39. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: An in vivo microdialysis study
40. Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: An in vivo microdialysis study
41. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis
42. Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT(1A) receptor antagonist, WAY-100635
43. Pindolol augmentation of treatment-resistant depressed patients
44. Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin(1A) (5-HT(1A)) receptors
45. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
46. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors
47. Augmentation of fluoxetine antidepressant action by pindolol: Analysis of clinical, pharmacokinetic and methodological factors
48. Distribution and cellular localization of mRNA coding for 5-HT(1A) receptor in the rat brain: Correlation with receptor binding
49. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT(1A) receptor antagonists in the dorsal raphe pathway: Role of somatodendritic autoreceptors
50. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus
51. Acute uptake inhibition increases extracellular serotonin in the rat forebrain
52. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine
53. 11C]WAY-100635: Effects of depression and antidepressant treatment
54. Effect of acute and repeated administration of 5-HT(1A) receptor agonists on 5-HT release in rat brain in vivo
55. The 5-HT(1A) receptor antagonist WAY-100635 induces a downregulation of 5-HT(1A) receptor sites in a human 5-HT(1A) clonal cell line
56. Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT(1A) receptor antagonists
57. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment
58. How long should pindolol be associated with paroxetine to improve the antidepressant response?
59. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: A controlled study